Medienmitteilungen

19. November 2009
454 Life Sciences Unveils New Bench Top Sequencer, Significant Improvements to the Genome Sequencer FLX System Including 1,000 bp Reads for 2010
454 Life Sciences, a Roche Company, announced today at the Association of Molecular Pathology Annual Meeting in Kissimmee, ... mehr

18. November 2009
New Cancer Research Tool: Roche's CIM-Plate 16 Enables Real-Time Analysis of Cell Migration on the xCELLigence System
Roche Applied Science announces the availability of the new CIM-Plate 16 for their xCELLigence System for cell analysis, for ... mehr

17. November 2009
Roche announces the 6000th installation of the cobas 6000 analyzer series
The cobas® 6000 analyzer series has strengthened Roche’s leading position in the in vitro diagnostics market by ... mehr

17. November 2009
Eurofins MWG Operon Joins Roche NimbleGen's Certified Service Provider Program for Targeted Enrichment and Sequencing Services
Roche NimbleGen is pleased to announce that Eurofins MWG Operon, an Ebersberg, Germany-based company, has officially become ... mehr

16. November 2009
FDA Grants Emergency Use Authorization to Roche's Assay for 2009 H1N1 Influenza Virus
Roche's RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 influenza virus has received emergency use authorization ... mehr

11. November 2009
Landmark study in The Lancet Oncology shows Xeloda reduces early breast cancer recurrence
Large, independent phase III randomised study in women with early breast cancer shows that adding Xeloda (capecitabine) to ... mehr

10. November 2009
Researchers Use 454 Sequencing System to Complete Draft Genome Sequence for Cassava
A team of academic, government and industry researchers has completed a first draft of the cassava (Manihot esculenta) genome. ... mehr

05. November 2009
Roche receives CE Mark certification for the second analytical module for cobas 8000 modular analyzer series
Roche announced today that CE Mark certification for the second clinical chemistry module for cobas 8000 modular analyzer ... mehr

03. November 2009
Roche NimbleGen Arrays Help Unveil the Secrets of Insidious Potato Blight
A large international team of researchers recently published the 240-megabase DNA sequence of Phytophthora infestans, a robust ... mehr

02. November 2009
Roche Applied Science Announces CGX Arrays Designed by Signature Genomics for Microarray-based Cytogenetic Analysis
Roche Applied Science will announce the European and Asia Pacific launch of the NimbleGen CGX arrays for microarray-based ... mehr

29. Oktober 2009
Norwegian Team Completes Cod Genome Using 454 Sequencing System
Scientists from a consortium of Norwegian marine and aquaculture institutions announced this week that they have generated ... mehr

27. Oktober 2009
Roche Molecular Systems Research Team Uses 454 Sequencing System for High-Resolution HLA Genotyping
A study published this month in the journal Tissue Antigens reports that researchers at Roche Molecular Systems in Pleasanton, ... mehr

22. Oktober 2009
Analysis of RNA Polymerase II Mutants using Roche's xCELLigence System
The C-terminal domain (CTD) of RNA Polymerase II consists of multiple repeats of an evolutionary conserved motif of seven ... mehr

22. Oktober 2009
Roche launches new professional Point of Care coagulation monitoring system
Well over two million patients on anticoagulation therapy with Vitamin K antagonists are currently tested using a CoaguChek® ... mehr

20. Oktober 2009
Roche and High Throughput Genomics Partner for Advanced Gene Expression Analysis Solution
Roche NimbleGen and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA), have ... mehr

14. Oktober 2009
DNA Link Announced as Roche NimbleGen's First Certified Service Provider for Targeted Enrichment and Sequencing Services
Roche NimbleGen, a Roche Company, has announced the first Certified Service Provider (CSP), DNA Link, Inc., who will provide ... mehr

13. Oktober 2009
Landmark Genotyping Study Demonstrates the Power of 454 Sequencing Systems for Immunogenetics
A study published online today in the prestigious Nature Medicine journal reports that researchers at the Wisconsin National ... mehr

06. Oktober 2009
Online Configuration of Custom qPCR Assays and Panels Now Available with RealTime ready Configurator from Roche
Roche announces the launch of RealTime ready Configurator, the latest innovation in the online configuration of custom qPCR ... mehr

06. Oktober 2009
The need to improve antithrombotic management
A new consensus article developed by a multidisciplinary expert group was published recently in the Journal of Thrombosis ... mehr

30. September 2009
Roche Launches New MagNA Pure 96 System: A Perfect Combination of Performance and High Throughput
The new MagNA Pure 96 System from Roche Applied Science has been designed and engineered to meet the needs for high throughput ... mehr

30. September 2009
A new era in blood glucose monitoring begins: The Accu-Chek Mobile system - the world’s first strip-free testing device
The first and unique strip-free monitoring system enables smooth, discreet and accurate testing wherever and whenever needed, ... mehr

30. September 2009
Preliminary study results show: New concept of Structured Testing can significantly help to improve diabetes therapy outcomes
The promising preliminary results of the Accu-Chek 360° View Outcome study suggest: Structured Testing can enable people ... mehr

29. September 2009
SAIC-Frederick and Roche Enter into a Research Collaboration on Technology Advancements for Cancer Gene Sequencing
National Cancer Institute contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International ... mehr

29. September 2009
Roche launches intelligent workflow solution for high volume labs
The cobas p 501/701 post-analytical unit for customized blood sample archiving helps lab professionals to save time, monitor ... mehr

23. September 2009
New data presented at ECCO/ESMO confirms benefits of bevacizumab (Avastin) based therapy for the first-line treatment of metastatic breast cancer
This update outlines data on bevacizumab in metastatic breast cancer presented at the joint ECCO 15 and ESMO 34 congress ... mehr

23. September 2009
Phase IV lung cancer study confirms the safety and outstanding efficacy benefit of Avastin-based therapy in a 'real world' setting
This update outlines the key data from four presentations on Avastin in advanced non-small cell lung cancer (NSCLC) at the ... mehr

17. September 2009
Roche's xCELLigence System and FuGENE HD Transfection Reagent minimize cytotoxic effects in the detection of bax-induced apoptosis
Transfection is a way to transiently or permanently deliver nucleic acids into eukaryotic cells to study functional effects ... mehr

10. September 2009
Nutlin-Induced Apoptosis Analyzed Using Roche's xCELLigence System and RealTime ready Focus Panels
The p53 tumor suppressor, a transcription factor that activates or inhibits hundreds of genes, either directly or indirectly, ... mehr

09. September 2009
Roche Diagnostics announces agreement with St Vincent's Hospital Sydney for Growth-Differentiation Factor-15 (GDF-15/MIC-1) cardiac test
Roche Diagnostics and St Vincent’s Hospital Sydney Limited today announced the signing of an exclusive license agreement ... mehr

08. September 2009
RiNA GmbH and 5 PRIME Acquire Roche RTS Protein Expression Portfolio
Roche (SIX: RO, ROG; OTCQX: RHHBY) and RiNA GmbH of Berlin have agreed to transfer the complete Roche Applied Science RTS ... mehr

26. August 2009
Roche xCELLigence System for Cell Analysis to Provide Predictive Mechanistic Information for Small Molecule Compounds.
The extent to which protein targets are modulated by drugs or small molecule compounds depends on a number of factors, including ... mehr

13. August 2009
Roche's xCELLigence System for Determination of Optimal Time Points for Gene and Protein Expression Analysis
The xCELLigence RTCA System from Roche Applied Science allows for label-free, continuous monitoring of cell phenotypic changes ... mehr

11. August 2009
New Roche Mycoplasma PCR Test Replaces Time-Consuming Culture Testing During Pharmaceutical Production
In July 2009 the new MycoTOOL PCR test from Roche Applied Science was approved by the European Medicines Agency (EMEA) for ... mehr

30. Juli 2009
454 Life Sciences and Roche NimbleGen Announce Collaboration with Eli Lilly and SeqWright to Sequence Genomic Regions Associated with Psychiatric Disease
454 Life Sciences, a Roche company, and Roche NimbleGen, both units of Roche Applied Science, have announced a collaboration ... mehr

28. Juli 2009
Roche and Google.org Start Initiative for Early Discovery of New Diseases
Roche and Google.org recently started a joint project to demonstrate the feasibility of developing a multidisciplinary surveillance, ... mehr

16. Juli 2009
Researchers to Decode Antarctic Ice Metagenome with the 454 Sequencing System, to Explore the Effects of Climate Change
For many years, researchers at the Alfred Wegener Institute (AWI) for Polar and Marine Research in Bremerhaven, Germany have ... mehr

14. Juli 2009
Roche NimbleGen CGH Arrays Enable Characterization of Novel Genomic Disorders Associated with Psychiatric Disease in Recent Studies
High-resolution comparative genomic hybridization (CGH) has rapidly emerged as the method of choice for molecular cytogenetic ... mehr

08. Juli 2009
The Research Institute of the Hospital Universitari Vall d'Hebron is the first Spanish Health Centre to Acquire High-Performance Sequencing Technology of 454 Life Sciences
The Research Institute of the Hospital Universitari Vall d'Hebron (IR-HUVH) in Barcelona is the first Spanish health ... mehr

02. Juli 2009
Roche NimbleGen CNV Arrays Selected for Landmark Korean Copy Number Variation Study
Roche NimbleGen has entered into a partnership with the Korea Centers for Disease Control and Prevention (KCDC) and Macrogen, ... mehr

25. Juni 2009
Roche Applied Science Announces Winners of 454 Life Sciences' 10GB Grant Program
Roche Applied Science announced today the winners of the 10 Gigabase Grant Program for DNA sequencing and transcriptome analysis ... mehr

11. Juni 2009
454 Life Sciences Celebrates a Revolution in Genomics - Announces the 454th Peer-Reviewed Publication Using the Genome Sequencer System
In September 2005, a paper published in the journal Nature introducing a novel, highly parallel sequencing system capable ... mehr

10. Juni 2009
High-Resolution Digital Imaging with Cedex HiRes from Roche Innovatis
Roche Innovatis has launched Cedex HiRes, the newest generation of image-based Cedex Cell Counter and Analyzer systems for ... mehr

09. Juni 2009
Roche's NimbleGen Sequence Capture Arrays and xCELLigence Cell Analysis System Are Among the Ten Top Innovative Products of 2008 in China
The Roche NimbleGen Sequence Capture Array and Roche's xCELLigence RTCA Instrument are among the ten most innovative ... mehr

05. Juni 2009
Roche and SeqWright Collaborate to Help Elucidate the Underlying Genetic Causes of Heart Disease
Utilizing next generation sequencing and the latest advancements in sequence capture, SeqWright, a world-wide leader in custom ... mehr

04. Juni 2009
High Throughput - Redefined: Roche's New LightCycler 1536 Real-Time PCR System
Large-scale, PCR-based gene analysis can only be performed if signals are generated, captured and analyzed in a highly reproducible ... mehr

03. Juni 2009
Roche NimbleGen Introduces the MS 200 Microarray Scanner, Unleashing the Full Potential of NimbleGen Arrays
Roche NimbleGen introduces a new high-resolution scanning instrument, the NimbleGen MS 200 Microarray Scanner. The MS 200 ... mehr

02. Juni 2009
The 454 Genome Sequencing System Detects a Novel Virus Responsible for South African Hemorrhagic Fever Outbreak
A study published online in PLoS Pathogens reports that researchers at Columbia University, the South African National Health ... mehr

01. Juni 2009
IMPACT study shows longer Valcyte treatment provides better protection against cytomegalovirus (CMV) disease
New Phase III study results presented for the first time today at the ninth annual American Transplant Congress 2009 (ATC) ... mehr

29. Mai 2009
Avastin plus commonly used chemotherapies improves the time breast cancer patients live without their disease getting worse
Results from the phase III RIBBON-1 study presented today at ASCO showed that patients with advanced HER2-negative breast ... mehr

28. Mai 2009
Genome Institute of Singapore and Roche NimbleGen: Tracking the Evolutionary Path of the novel H1N1 Influenza A
The recent outbreak of the flu virus, the new strain of Influenza A (nH1N1), has rapidly spread around the world. mehr

28. Mai 2009
New form of targeted therapy offers further hope to patients with advanced HER2-positive breast cancer
Final results from a phase II study presented at ASCO show that 25% of women with advanced HER2-positive breast cancer experienced ... mehr

26. Mai 2009
Roche Launches New PCR Assay for Tuberculosis Testing in South Africa
Roche Diagnostics today announced the launch of a new tuberculosis test for South Africa. mehr

25. Mai 2009
Roche Applied Science Opens Application Support Center in Shanghai
Roche Applied Science today announced the opening of the new Application Support Center (ASC) in Shanghai, China. mehr

18. Mai 2009
Roche joins forces to innovate toxicity testing and to reduce animal experimentation
Today, Roche opened the Joint Science & Technology Laboratory in Basel, where Roche Pharma scientists are using the innovative ... mehr

14. Mai 2009
Roche Launches Complete Detection Kit for Influenza A /H1N1 on LightCycler System
Roche Applied Science announced today the availability of a new detection kit for the Influenza A/H1N1 virus. The detection ... mehr

12. Mai 2009
454 Sequencing Systems Enable High Quality De Novo Assembly of Oil Palm Genome
At a press conference held today in Kuala Lumpur, Malaysia, a team of researchers announced the complete sequencing, assembly ... mehr

07. Mai 2009
A Set of Firsts: Roche NimbleGen CGH Microarrays Enable the First Maps of Genome-Wide DNA Copy Number Variation (CNV) in Dogs
The unique evolutionary history of dogs (Canis lupus familiaris), domesticated over 14,000 years ago, includes artificial ... mehr

05. Mai 2009
Roche RT-PCR technology used for TIB MOLBIOL's H1N1 test
TIB MOLBIOL, the Berlin-based cooperation partner of Roche Applied Science announced today the development of a LightMix test ... mehr

30. April 2009
Real-time and Dynamic Monitoring of Virus-mediated Cytopathogenicity with Roche's xCELLigence System
To understand overall infectivity, virus progression and disease-onset it is important to perform a detailed examination of ... mehr

28. April 2009
Roche honored with a MarketingSherpa award
The Roche Applied Sciences Imaginality e-mail campaign took top honors at this year's MarketingSherpa Awards in Miami, ... mehr

25. April 2009
Ground-breaking combination of all-oral agents demonstrates potential as hepatitis C treatment regimen
mehr

25. April 2009
Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C
Roche and Pharmasset, Inc. (Nasdaq: VRUS) today announced that the first patient has been dosed in a Phase IIb study of R7128, ... mehr

23. April 2009
454 Life Sciences Announces Comprehensive Solution for De Novo Sequencing and Assembly of Increasingly Complex Genomes
The GS FLX Titanium Series multi-span paired end kits and improved assembler software solidify 454 Sequencing System’s ... mehr

21. April 2009
Roche NimbleGen and Sigma-Aldrich Collaborate to Advance Epigenetic Research
Roche NimbleGen and Sigma-Aldrich (Nasdaq: SIAL) have started a collaboration to further chromatin immunoprecipitation-on-microarray ... mehr

21. April 2009
Newly published study shows that re-treatment with Pegasys provides hepatitis C patients with a second chance for a cure
REPEAT study in Annals of Internal Medicine highlights a new solution for previously-treated hepatitis C patients mehr

07. April 2009
Researchers Uncover Low-Frequency Hepatitis B Drug-Resistant Mutations Using 454 Sequencing Systems.
A study published online last week in the Journal of Infectious Disease reports that ultra-deep sequencing has the ability ... mehr

02. April 2009
454 Sequencing Boosts Genomics Research in Spain: Genome Sequencer FLX System Installed at University of Barcelona
454 Sequencing is now boosting genomics research at the University of Barcelona (UB). UB has recently acquired a Genome Sequencer ... mehr

01. April 2009
Roche Completes xCELLigence Family of Products with the New, Highly Flexible xCELLigence RTCA DP Instrument
Following the launches of the xCELLigence RTCA SP Instrument and the RTCA MP Instrument last year, Roche Applied Science has ... mehr

31. März 2009
Roche NimbleGen CGH Microarrays Further Our Understanding of Childhood Acute Lymphoblastic Leukemia
The most commonly diagnosed form of childhood leukemia, acute lymphoblastic leukemia (ALL), often responds well to biologically-targeted ... mehr

12. März 2009
Roche Announces Sequence Capture Services for Genomic Enrichment Available through Service Partner SeqWright
Roche NimbleGen announces Sequence Capture services now available through a partnership with SeqWright, a world-wide leader ... mehr

05. März 2009
Next-Generation Sequencing Uncovers Genetic Variation Linking Type 1 Diabetes with Enterovirus Infection
A study by Nejentsev et al. published online today in Science reports that researchers have discovered a group of rare variants ... mehr

04. März 2009
Researchers Use 454 Sequencing System for Rapid Sequencing of Avian Influenzas
A team of researchers at the Institute of Diagnostic Virology, Friedrich-Loeffler-Institute Insel Riems, in Germany has developed ... mehr

26. Februar 2009
Roche NimbleGen Microarrays Selected as Technology of Choice for the Neuromuscular Disorder -Chip Consortium
The NMD-Chip Consortium, an initiative of the Seventh Framework Programme for Research and Technological Development, recently ... mehr

25. Februar 2009
Analyzing the Effect of Gene Knock-down in Real-Time Using Roche´s xCELLigence System
The RNA-interference has developed to an extremely powerful tool for loss-of-function studies and has substantially stimulated ... mehr

18. Februar 2009
A 454 Sequencing Study Reveals New Insights in Drug Resistance and Tropism Associated with the New HIV Integrase and Entry Inhibitor Therapy Classes
New data from two studies, presented last week at the 16th Conference on Retroviruses and Opportunistic Infections (CROI) ... mehr

18. Februar 2009
Improving the detection of myocardial injury: Roche launches highly sensitive diagnostic test
Roche announced today the launch of a highly sensitive Troponin T assay in Europe as well as other regions recognizing the ... mehr

17. Februar 2009
454 Sequencing Identifies Early Stage HIV Drug Resistance - Low-level Mutations may have Significant Impact on Clinical Outcomes
Retrospective research study shows that even the lowest levels of resistance mutations could lead to early treatment failure. mehr

12. Februar 2009
454 Life Sciences and Max Planck Institute Complete Draft 1X Sequence of Neanderthal Genome
Completion of more than 3 billion bases of sequenced Neanderthal DNA brings closure to the sequencing stage of an ambitious ... mehr

03. Februar 2009
Roche NimbleGen and 454 Life Sciences Capture the Targeted Resequencing Market on a Global Scale
Roche NimbleGen and 454 Life Sciences are capturing the targeted resequencing market as researchers in laboratories worldwide ... mehr

02. Februar 2009
Knowledge and competence in point of care testing - the cobas academy
Roche Diagnostics has launched a new knowledge and competence support platform, which is designed to improve and test user ... mehr

29. Januar 2009
454 Sequencing Helps Identify Herpes-like Viruses That May Contribute to Pandemic Decline of Tropical Reefs
In an effort to determine the influence of viral pathogens in declining coral health, researchers at San Diego State University ... mehr

27. Januar 2009
Roche Applied Science Makes Exome Sequencing a Reality, a Giant Step Towards Personalized Medicine
A key milestone for personalized medicine has been achieved by two Roche Applied Science companies, Roche NimbleGen and 454 ... mehr

22. Januar 2009
Roche NimbleGen Microarray Technology Enables the Highest-Resolution Map of Human Genome Copy Number Variation
Roche NimbleGen's CGH microarray platform was used to generate the highest-resolution map of human genome copy number ... mehr

14. Januar 2009
Roche Diagnostics announces agreement with Hannover Medical School for Growth-Differentiation Factor-15 (GDF-15) cardiac test
Roche Diagnostics, Hannover Medical School, and Ascenion today announced the signing of an exclusive license agreement which ... mehr

09. Januar 2009
Roche NimbleGen partners with Biogemma on the development of Sequence Capture technology for targeted high-throughput sequencing of crop genomes
Roche NimbleGen and Biogemma entered into a research agreement which will apply Roche NimbleGen’s array-based Sequence ... mehr

06. Januar 2009
Roche Diagnostics announces CE launch of first diagnostic Preeclampsia Test
Roche Diagnostics announced today the CE launch of the first in vitro diagnostic tests for preeclampsia. The PlGF and sFlt-1 ... mehr